The National Interest is an award-winning online publication focusing on defense issues, national security, military affairs and hardware, foreign policy, and U.S. politics. The National Interest ...

The government is set to issue new guidelines for Muslim participation in Non-Muslim celebrations and ceremonies, said ...

The government is set to issue new guidelines for Muslim participation in Non-Muslim celebrations and ceremonies, said ...

Santander Bank, N.A., a division of Spain's Banco Santander (SAN) said the company's Openbank digital banking platform ...

Sitharaman is set to present her record 8th consecutive budget today at 11 am in the Lok Sabha. The budget speech will outline the government's fiscal policies, revenue and expenditure proposals, ...

Congress leader Sandeep Dixit has expressed doubts over the Union Budget 2025, saying that the ruling party have been presenting it for 10-11 years and have done nothing substantial.Speaking to ANI, ...

The ISS National Lab releases its annual report outlining the research work done on the international space station over the past year. The headline figures for space-based R&D include sponsoring 103 ...

Britain's Chancellor Rachel Reeves has unveiled her plan for economic growth, announcing a number of projects, including reviving a plan to expand London's Heathrow Airport, which has already drawn ...

They complete emblem logos by carving out branded space rather than confining marks under cookie-cutter constraints. Like unique picture frames, tailored graphic outlines showcase what makes each logo ...

LONDON (AP) — Advanced artificial intelligence systems have the potential to create extreme new risks, such as fueling widespread job losses, enabling terrorism or running amok, experts said in ...

LONDON (AP) — A new report says advanced artificial intelligence systems have the potential to create extreme new risks, such as fueling widespread job losses, enabling terrorism or running amok.

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced its 2025 priorities and ...